MARIA CUEVAS-ALTAMIRANO: Open Payments
NPI 1700456738 · VICTORVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,140 in 87 payments from 15 companies in 2025. Trend: 2023 $1,139 · 2024 $2,291 · 2025 $2,140
Food & beverage: $2,140
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 9 | $400 |
| ABBVIE INC. | 29 | $381 |
| Phathom Pharmaceuticals, Inc. | 6 | $272 |
| Gilead Sciences, Inc. | 9 | $260 |
| Ardelyx, Inc. | 9 | $254 |
| Regeneron Healthcare Solutions, Inc. | 4 | $175 |
| Janssen Biotech, Inc. | 9 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $46 |
| Ipsen Biopharmaceuticals, Inc | 1 | $34 |
Products named: REZDIFFRA, VOQUEZNA, IBSRELA, DUPIXENT, MAVYRET, TREMFYA, LINZESS, ENTYVIO.
Industry payments across CA — which companies pay providers there.
